Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{bcd2f41ef24f4253a32fc6af52447c51,
title = "Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report",
abstract = "INTRODUCTION: In 2016, the WHO classification of diffuse astrocytoma began to include isocitrate dehydrogenase (IDH) mutation in addition to histology.RESULTS: We here demonstrate a case where a 14-year-old boy presented with a parietal tumor with no histological evidence of neoplasia but with an IDH1 mutation. Due to the IDH1 R132H mutation, the patient was diagnosed with diffuse astrocytoma WHO grade II and underwent successful gross total resection of this near-eloquently located tumor.CONCLUSION: This case exemplifies how inclusion of immunohistochemistry in tumor classification alters surgical strategy and might improve accuracy and time to diagnosis.",
keywords = "Journal Article",
author = "S{\o}ndergaard, {Christian Baastrup} and David Scheie and Sehested, {Astrid Marie} and Jane Skj{\o}th-Rasmussen",
year = "2017",
month = "7",
doi = "10.1007/s00381-017-3348-7",
language = "English",
volume = "33",
pages = "1217--1220",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer",
number = "7",

}

RIS

TY - JOUR

T1 - Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report

AU - Søndergaard, Christian Baastrup

AU - Scheie, David

AU - Sehested, Astrid Marie

AU - Skjøth-Rasmussen, Jane

PY - 2017/7

Y1 - 2017/7

N2 - INTRODUCTION: In 2016, the WHO classification of diffuse astrocytoma began to include isocitrate dehydrogenase (IDH) mutation in addition to histology.RESULTS: We here demonstrate a case where a 14-year-old boy presented with a parietal tumor with no histological evidence of neoplasia but with an IDH1 mutation. Due to the IDH1 R132H mutation, the patient was diagnosed with diffuse astrocytoma WHO grade II and underwent successful gross total resection of this near-eloquently located tumor.CONCLUSION: This case exemplifies how inclusion of immunohistochemistry in tumor classification alters surgical strategy and might improve accuracy and time to diagnosis.

AB - INTRODUCTION: In 2016, the WHO classification of diffuse astrocytoma began to include isocitrate dehydrogenase (IDH) mutation in addition to histology.RESULTS: We here demonstrate a case where a 14-year-old boy presented with a parietal tumor with no histological evidence of neoplasia but with an IDH1 mutation. Due to the IDH1 R132H mutation, the patient was diagnosed with diffuse astrocytoma WHO grade II and underwent successful gross total resection of this near-eloquently located tumor.CONCLUSION: This case exemplifies how inclusion of immunohistochemistry in tumor classification alters surgical strategy and might improve accuracy and time to diagnosis.

KW - Journal Article

U2 - 10.1007/s00381-017-3348-7

DO - 10.1007/s00381-017-3348-7

M3 - Journal article

VL - 33

SP - 1217

EP - 1220

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 7

ER -

ID: 49947654